BeidermanJMelmedRDPatelA; SPD503 Study Group. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. Pediatrics. 2008;121:e73-e84.
3.
BiedermanJMelmedRDPatelAMcBurnettKDonahueJLyneA. Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD. CNS Spectr. 2008;13:1047-1055.
4.
SalleeFRLyneAWigalTMcGoughJJ. Long-term safety and efficacy of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2009;19:215-226.
5.
SalleeFRMcGoughJWigalTDonahueJLyneABiedermanJ. Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2009;48:155-165.
6.
KhanMAJainGSoltysSMTakahashiA. A case of excessive weight gain with guanfacine extended release: 9.53 kg in 4 weeks. J Child Adolesc Psychopharmacol. 2012;22:256-257.
